Initial Results of Oral Thrombolytic Agent Clinical Application

Abstract

At the moment, there is no oral thrombolytic drug on the world pharmaceutical market. The drug Trombovazim, which has a thrombolytic effect under oral administration, has been registered in Russia. It differs from all thrombolytics—it has a fundamentally different mechanism of action. It is not an activator of plasminogen. It independently dissolves a thrombus. It is a direct thrombolytic. The article presents the materials of the initial studies of the drug Trombovazim.

Keywords

• thrombosis of the venous system
• thrombolytic therapy
• oral thrombolytic